(Page 11 of 24)
|NEXT IMAGE >>|
|Reinventing Biotech’s Business Model— Carl Weissman (center) and Dave McElligott of Accelerator described how their model has evolved, keeping companies like Groove Biopharma in the Accelerator nest a little while longer to save money before they hopefully fly away as independent companies.|
|Photo by Luke Timmerman|
By posting a comment, you agree to our terms and conditions.